glp-1 receptor agonist antipsychotic weight gain study Semaglutide for the treatment of antipsychotic-associated in patients not responding to metformin – a case series GLP-1 Agonists For Obesity In
Description
Their paper, published in 2009, was the first to report weight loss effects of dual-agonist drugs
Lifestyle modifications and medications serve as adjuncts, not primary therapy
The psychological impact of treatment duration should not be overlooked
Can GLP-1 cause hair loss
Mol Neurobiol (2017) 54(10):807189
The review found that serious anesthesia risks linked to these drugs are uncommon for most patients and can usually be managed through individualized planning rather than stopping the medication
